Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565975
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
Characteristics and Outcomes of Acute Myeloid Leukemia AML Patients Treated With Oral-Azacitidine Maintenance Therapy in France
Sponsor:
None
Organization:
None
Study Overview
Official Title:
RELION Study Characteristics and Outcomes of the Patient Population With Acute Myeloid Leukemia in Remission Treated With Oral Azacitidine Maintenance in France
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RELION
Brief Summary:
The purpose of this study is to collect and evaluate real-world data to describe the outcomes patient characteristics safety profile and treatment patterns of oral azacitidine prescribed as maintenance treatment after frontline treatment or second remission for acute myeloid leukemia in France
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None